John Libbey Eurotext

Médecine thérapeutique / Médecine de la reproduction, gynécologie et endocrinologie

Actuality in ovulation trigger Volume 19, issue 3, Juillet-Août-Septembre 2017

Author
Clinique Jean-Villar, avenue Maryse Bastié, Bruges, Belgique
* Tirés à part
  • Key words: IVF, GnRH agonist trigger, hCG trigger, ovarian hyperstimulation syndrome, luteal phase support
  • DOI : 10.1684/mte.2017.0667
  • Page(s) : 193-6
  • Published in: 2017

Antagonist protocols have opened the possibility of new triggering modes, paving the way for “OHSS free clinic” and for a significant evolution towards a more efficient, safer patient care. Thus, ovulation can be triggered by GnRH agonists, either alone – the latter applies particularly if the embryo transfer must be shifted forward another cycle – either together with a small dose of hCG (duo trigger), especially for bad responders or after a history of oocyte immaturity. In the case of a fresh transfer, several solutions of luteal support, either by agonists or by small doses of hCG, can be proposed with satisfying results. The main works on the issue are listed here.